Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jezrom Self-Fordham"'
Autor:
Yaara Ofir -Rosenfeld, Oliver Rausch, Jerry McMahon, Lina Vasiliauskaite, Claire Saunders, Alexandra Sapetschnig, Georgia Tsagkogeorga, Mark Albertella, Marie Carkill, Jezrom Self-Fordham, Josefin-Beate Holz
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44d4557b3a1ecfe259d4c2baf25206c0
https://doi.org/10.1136/jitc-2022-sitc2022.1373
https://doi.org/10.1136/jitc-2022-sitc2022.1373
Autor:
Marie Carkill, Kaitlin Mitchell, Lauren Kelsey, Jezrom Self-Fordham, Nunan Robert, Louise Brackenbury
Publikováno v:
Cancer Research. 83:6377-6377
The cancer treatment landscape has transformed following the clinical success of early immune checkpoint inhibitors (ICI) which demonstrate the remarkable power of harnessing the immune system to treat a variety of metastatic cancers. Despite the suc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd117d751b42acafb3ee53fc803062a0
https://doi.org/10.1158/1538-7445.am2023-6377
https://doi.org/10.1158/1538-7445.am2023-6377
Autor:
Lauren Kelsey, Karin Latta, Joey Kolb, Bincy John, Ilona Aylott, Daniel Rocca, Alexandru Bacita, Christopher Kirkham, Patrick Walters, Charlotte Humphery, Lorena Sueiro Ballesteros, Jezrom Self-Fordham, Louise Brackenbury, Chassidy Hall, Harris David, Julia Schueler, Robert Nunan
Publikováno v:
Cancer Research. 83:4097-4097
Chimeric Antigen Receptor (CAR)-T cell therapy has achieved great success in treating a variety of liquid tumors, in particular CD19+ lymphomas. CAR technology is advancing rapidly, with notable improvements in efficacy, safety and complexity as huma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51a89f5fb6184aade91288ca0c18f921
https://doi.org/10.1158/1538-7445.am2023-4097
https://doi.org/10.1158/1538-7445.am2023-4097
Autor:
Lauren Kelsey, Jezrom Self-Fordham, Eva Oswald, Ilona Aylott, Daniel Rocca, Robert Nunan, David Harris, Julia Schueler, Rhiannon Jenkinson
Publikováno v:
Cancer Research. 82:2843-2843
Chimeric Antigen Receptor (CAR)-T cell therapy has achieved great success with specificity, efficacy, safety and ingenuity. CAR cell technology is advancing rapidly, with ever increasing capabilities for cancer treatment both with regard to tumor typ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4125ea81f29e47f837986285b6bc1b92
https://doi.org/10.1158/1538-7445.am2022-2843
https://doi.org/10.1158/1538-7445.am2022-2843
Autor:
Jezrom Self-Fordham, Robert Nunan
Publikováno v:
Genetic Engineering & Biotechnology News. 39:63-65
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e1294dcecc95c10cc18106ad047f6fe
https://doi.org/10.1089/gen.39.08.20
https://doi.org/10.1089/gen.39.08.20
Autor:
Enrique Garcia-Alvarez, Robert Nunan, Jezrom Self-Fordham, Michelle Yap, Anna Pascoe, Marie Carkill, S. Rhiannon Jenkinson, Louise Brackenbury
Publikováno v:
Cancer Research. 80:2824-2824
Cellular immunotherapy is emerging as a fifth pillar of cancer treatment. Clinical efficacy has been proven for a variety of cancers; however, its true potential has yet to be unlocked. Development of reliable and mechanistically appropriate in vitro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3d886fd9832541ae2b21aa64cbcc12a
https://doi.org/10.1158/1538-7445.am2020-2824
https://doi.org/10.1158/1538-7445.am2020-2824